Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Defining the Role of Physiotherapy in Palliative Care in Multiple Sclerosis.
Individual Neuronal Subtypes Exhibit Diversity in CNS Myelination Mediated by Synaptic Vesicle Release.
Episode 5 with Dr. Anne Cross on the year in MS research
Differences in the burden of psychiatric comorbidity in MS vs the general population.
Fatigue and Comorbidities in Multiple Sclerosis.
Glatiramer acetate inhibits degradation of collagen II by suppressing the activity of interferon regulatory factor-1.
Treatment with retinoid X receptor agonist IRX4204 ameliorates experimental autoimmune encephalomyelitis.
Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.
Multiple sclerosis: Could Helicobacter pylori provide protection against multiple sclerosis?
Identification of naturally occurring Fatty acids of the myelin sheath that resolve neuroinflammation.
[Reduction of spastic increased muscle tone in multiple sclerosis by the nonopioid analgesic flupirtine].
Masitinib in Patients with Progressive or Relapse-Free Secondary Multiple Sclerosis
Multiple sclerosis review.
Interferon beta-1b therapy in chronic viral dilated cardiomyopathy--is there a role for specific therapy?
The role of global and regional gray matter volume decrease in multiple sclerosis.
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
Sox10 Expression in Goldfish Retina and Optic Nerve Head in Controls and after the Application of Two Different Lesion Paradigms.
Assessment of cancer risk with β-interferon treatment for multiple sclerosis.
Population pharmacokinetics of ponesimod and its primary metabolites in healthy and organ-impaired subjects.
Glatiramer acetate induced hepatotoxicity.
A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study.
IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.
Interferon-beta is a potent promoter of nerve growth factor production by astrocytes.
Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate.

Pages